C07H 9/02
The hetero ring containing only oxygen as ring hetero atoms
Official title: the hetero ring containing only oxygen as ring hetero atoms
C07H9/02 (The hetero ring containing only oxygen as ring hetero atoms) appears on 251 US grants and 143 published applications in this corpus.
Search patents in C07H- Granted patents
- 251
- Published applications
- 143
- Assignees
- 168
- Inventors
- 644
- Latest grant
- 30 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 6 | 0 |
| 1978 | 5 | 0 |
| 1979 | 4 | 0 |
| 1980 | 4 | 0 |
| 1981 | 4 | 0 |
| 1982 | 4 | 0 |
| 1983 | 4 | 0 |
| 1984 | 9 | 0 |
| 1985 | 9 | 0 |
| 1986 | 7 | 0 |
| 1987 | 7 | 0 |
| 1988 | 4 | 0 |
| 1989 | 4 | 0 |
| 1990 | 2 | 0 |
| 1991 | 5 | 0 |
| 1992 | 4 | 0 |
| 1993 | 4 | 0 |
| 1994 | 5 | 0 |
| 1995 | 7 | 0 |
| 1996 | 2 | 0 |
| 1997 | 9 | 0 |
| 1998 | 6 | 0 |
| 1999 | 9 | 0 |
| 2000 | 5 | 0 |
| 2001 | 4 | 0 |
| 2002 | 6 | 3 |
| 2003 | 10 | 11 |
| 2004 | 3 | 16 |
| 2005 | 5 | 6 |
| 2006 | 10 | 7 |
| 2007 | 2 | 4 |
| 2008 | 6 | 7 |
| 2009 | 6 | 4 |
| 2010 | 4 | 6 |
| 2011 | 5 | 5 |
| 2012 | 4 | 9 |
| 2013 | 6 | 3 |
| 2014 | 7 | 7 |
| 2015 | 5 | 8 |
| 2016 | 4 | 2 |
| 2017 | 3 | 4 |
| 2018 | 4 | 3 |
| 2019 | 3 | 2 |
| 2020 | 3 | 2 |
| 2021 | 3 | 5 |
| 2022 | 2 | 4 |
| 2023 | 3 | 4 |
| 2024 | 4 | 10 |
| 2025 | 3 | 9 |
| 2026 | 3 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- ASGPR-binding compounds for the degradation of extracellular proteins30 Jun 2026US 12,667,620 B2Avilar Therapeutics, Inc.
- ASGPR-binding compounds for the degradation of extracellular proteins12 May 2026US 12,622,972 B2Avilar Therapeutics, Inc.
- Renewable monomer and polymer thereof5 May 2026US 12,617,800 B2Ecole Polytechnique Federale De Lausanne (Epfl)
- Glucopyranosyl derivatives and their uses10 Jun 2025US 12,324,812 B2Sunshine Lake Pharma Co., Ltd.
- ASGPR-binding compounds for the degradation of extracellular proteins6 May 2025US 12,290,568 B2Avilar Therapeutics, Inc.
- A unified strategy for the total syntheses of eribulin and a macrolactam analogue of halichondrin b3 Sep 2026US 2026/0258052 A1William Marsh Rice University
- Method for preparing an at least partially acetal-protected sugar8 Jan 2026US 2026/0008802 A1
- Asgpr-binding compounds for the degradation of extracellular proteins6 Nov 2025US 2025/0339541 A1Avilar Therapeutics, Inc.
- Programmable selective acylation of polyols30 Oct 2025US 2025/0332271 A1Nanyang Technological University
- Biobased surfactants31 Jul 2025US 2025/0243233 A1
Most cited
By later US patents
- L-ribo-LNA analogues553US 7,053,207 B2Exiqon A/S · 2006
- Xylo-LNA analogues255US 7,084,125 B2Exiqon A/S · 2006
- Bis-modified bicyclic nucleic acid analogs253US 7,666,854 B2Isis Pharmaceuticals, Inc. · 2010
- Antidiabetic 3,4,5-trihydroxypiperidines252US 4,639,436 ABayer Aktiengesellschaft · 1987
- Anticonvulsant sulfamate derivatives134US 4,513,006 AMcNeil Lab, Inc. · 1985